StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) stock

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.43−0.16 (-26.57%)

Close on Nov 17, 2026Market cap $6.56MP/E –Yield –

Dare Bioscience gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2025 it was 71.3%, against 100.0% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202571.3%−28.7
FY2024Dec 31, 2024100.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-70.6%–
Q1 FY2026Mar 31, 2026-58.9%–
Q1 FY2025Mar 31, 2025100.0%–

More Dare Bioscience figures

See a number that looks wrong?